Hematoma/seroma development, I&D, and wound dehiscence in patients who received vs did not receive chemoprophylaxis.
| Hematomas/Seromas, I&D, and Wound Dehiscence | Inpatient Chemoprophylaxis | ||
| No (n = 316) | Yes (n = 316) | P | |
| All hematomas/seroma | 4 (1.3%) | 4 (1.3%) | >0.99 |
| Superficial seromas/hematomas | 1 (0.3%) | 1 (0.3%) | >0.99 |
| Deep seromas/hematomas | 2 (0.6%) | 3 (0.9%) | 0.653 |
| Canal/epidural hematomas | 1 (0.3%) | 0 (0.0%) | 0.317 |
| All hematomas/seromas diagnosis date (POD) | 35.50 ± 33.56 | 37.67 ± 47.48 | 0.946 |
| I&D procedure | 2 (0.6%) | 2 (0.6%) | >0.99 |
| Date of I&D (POD) | 37.00 ± 48.08 | 13.00 ± 11.31 | 0.563 |
| Wound dehiscence | 0 (0.0%) | 0 (0.0%) | - |
| Moist wound or dressing | 80 (25.3%) | 125 (39.6%) | <0.001 |
| Avg drain duration, d | 3.77 ± 2.74 | 4.60 ± 1.953 | <0.001 |
| Avg daily drainage, mL | 146.96 ± 96.35 | 157.64 ± 104.13 | 0.238 |
Abbreviations: I&D, incision and drainage; POD, postoperative day.
Note: Data presented as mean ± SD or n (%). Bolded values are statistically significant (P < 0.05).